Atlas Trials

To Evaluate HU-045 in the Treatment of Glabellar Lines(Phase III)

Clinical trial NCT06205797 · RECRUITING

Trial details

NCT number
NCT06205797
Sponsor
Huons Biopharma
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Glabellar Lines
Start date
2024-06-20
Primary completion
2024-11-30
Enrollment
312

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.